Page 1266 - Clinical Immunology_ Principles and Practice ( PDFDrive )
P. 1266
CHaPter 90 Vaccines 1226.e1
MUL t IPL e -CHOIC e QU e S t IO n S
1. The physician often recognized as the “father of vaccinology” recommendations for each vaccine based on the age of the
is: patient, and other indications. In the 2017 schedule, these
A. James Phipps included:
B. Robert Koch A. All adults (persons ≥19 years of age) should receive annual
C. Edward Jenner influenza vaccination; a tetanus–diphtheria–acellular
D. Louis Pasteur pertussis (Tdap) vaccine once, followed by tetanus boosters
every 10 years; zoster vaccination at 60 years of age; and
2. The polysaccharide vaccines developed for the prevention of
bacterial diseases caused by pathogenic organisms, such as pneumococcal vaccination at 65 years of age.
Haemophilus influenzae, Neisseria meningitidis, and Streptococ- B. Other vaccines indicated for certain risk factors, including
cus pneumoniae, became much more useful upon conjugation medical conditions (e.g., immunocompromising conditions,
with: kidney failure, diabetes) or life style, occupational, or other
A. Lipids conditions (e.g., pregnancy, men who have sex with men,
B. Small molecule metabolites health care personnel).
C. Proteins C. Live vaccines (varicella, zoster, and measles–mumps–rubella
D. Polymers [MMR]) are contraindicated for pregnant women,
immunocompromised hosts, and in those with human
3. The Advisory Committee on Immunization Practices immunodeficiency virus [HIV] infection when the CD4+
(ACIP) of the US Centers for Disease Control and Prevention T-cell absolute count is below 200 cells/µL.
(CDC) in its adult immunization schedule makes annual D. All of the above are correct.

